Community post

Melissa Cammuso (The Ottawa Hospital) and colleagues have published a preprint in medRxiv on the first use of phage therapy in Canada for life-threatening, MDR Staphylococcus epidermidis periprosthetic joint infection. This ‘n of 1 trial’ describes how the phage was administered intra-articularly and intravenously, leading to sustained clinical improvement.